ALC Alcon Inc.

SWX · CH · Healthcare · Medical Instruments & Supplies · alcon.com

53.10CHF+0.04%Mkt Cap: 29.28B $P/E: 50.55Today

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$143.60BUSDP/E 46.6

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

$26.51BUSDP/E 48.2

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation

$14.98BUSDP/E 10.8

BAX

Baxter International Inc.

$12.52BUSD

COO

The Cooper Companies, Inc.

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

ALGN

Align Technology, Inc.

Bausch + Lomb Corporation

$6.13BUSD

BLCO

Bausch + Lomb Corporation

$6.35BUSD

Key Statistics

Company

Market Cap29.28B USD

Enterprise Value33.54B USD

Revenue (TTM)12.40B USD

Gross Profit6.56B USD

Net Income (TTM)1.12B USD

Revenue/Share22.21 CHF

Last Price53.10 CHF

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees25.0K

CountryCH

SectorHealthcare

IndustryMedical Instruments & Supplies

ISINCH0432492467

Valuation

P/E (Trailing)50.55

P/E (Forward)14.48

PEG1.13

EV/EBITDA12.22

EV/Revenue2.71

P/S2.35

P/B1.42

EPS (TTM)1.09

EPS (Forward)3.65

52W Range

47.8026% of range68.34

52W High68.34 CHF

52W Low47.80 CHF

Profitability

Gross Margin55.24%

Oper. Margin14.63%

EBITDA Margin22.13%

Profit Margin9.42%

ROE4.45%

ROA3.11%

Growth

Revenue Growth8.70%

Earnings Growth—

Cash Flow & Leverage

Operating CF2.59B USD

CapEx (TTM)756.68M USD

FCF Margin11.72%

FCF Yield4.96%

Net Debt4.38B USD

Net Debt/EBITDA1.60

Balance Sheet

Debt/Equity0.02

Current Ratio2.09

Quick Ratio1.12

Book Value/Sh37.26 CHF

Cash/Share3.01 CHF

Dividends

Fwd Div Rate0.28 CHF

Trail. Div Rate0.35 CHF

Div. Yield0.53%

5Y Avg Yield0.29%

Payout Ratio26.56%

Ex-Div DateMay 5, 2026

Pay DateMay 15, 2025

Analyst Consensus

Rating1.6 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)75.69 CHF

Upside (mean)+42.6%

Target Range49.11 CHF – 87.26 CHF

49.11+42.6% to mean87.26

# Analysts17

Ownership

Shares Out.483.40M

Float481.83M

Insiders0.20%

Institutions63.57%

Technical

SMA 5056.60 (-6.2%)

SMA 20058.07 (-8.6%)

Beta0.70

S&P 52W Chg14.58%

Avg Vol (30d)963.15K

Avg Vol (10d)879.40K

Technical Indicators

RSI (14)38.2

MACD-0.9577

MACD Signal-0.9391

MACD Hist.-0.0186

BB Upper55.91 CHF

BB Middle54.06 CHF

BB Lower52.22 CHF

BB Width6.82%

ATR (14)1.056 CHF

Vol Ratio (20d)0.62x